Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment
Sponsor: ViiV Healthcare
Summary
The purpose of this study is to provide continued access to the study treatment for participants from previous ViiV Healthcare studies who are still benefiting from it and do not have local access after completing the parent study. This continued access will also allow further collection of safety data. Eligible participants are those who completed a ViiV Healthcare-sponsored or collaborative parent study and are currently experiencing clinical benefit. The Sponsor will periodically review the study to consider other treatment access options.
Official title: A Phase 3b, Open-label, Multicenter, Continued Access Study for Participants Transitioning From ViiV Healthcare Sponsored or ViiV Healthcare Collaborative Parent Studies for HIV Treatment
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
183
Start Date
2026-05-08
Completion Date
2030-12-30
Last Updated
2026-02-06
Healthy Volunteers
No
Conditions
Interventions
Fostemsavir
Participants receive oral tablets with the dosages depending on the weight of the participants.
Dolutegravir (DTG)/ Lamivudine (3TC)
Participants receive oral tablets with the dosages depending on the weight of the participants.